PM360

JUNE 23, 2023

Press Release Contact: Kayla Walsh Awards Coordinator, PM360 646-300-8114 kayla.walsh@pm360online.com PM360 Now Accepting Entries for 2024 Pharma Choice Awards Call for the Best Healthcare Creative from the Past Year NEW YORK, NY, June 22, 2023 : The 2024 PM360 Pharma Choice Awards are officially open for entries.

Pharma 52

Pharma Marketing Healthcare Healthcare 52

Pharma Marketing Network

DECEMBER 12, 2023

Upcoming Informa Connect Events: Speaker Programs Summit – February 26-28, 2024 Event Name: Rare Disease Summit – March 19-21, 2024 PAP – Patient Assistance & Access Programs – March 19-21, 2024 Hub and Specialty Pharmacy Models East – March 19-21, 2024 Pharma Forum – March 24-27, 2024 Pharmaceutical Compliance Congress (..)

Education 40

Education Networking Pharma Pharmaceutical 40

European Pharmaceutical Review

MAY 25, 2023

CPHI’s Pharmapack Awards 2024 are open for submissions. The Pharmapack Awards 2024 (January 24-25 2024) will be held during the event’s opening day. In keeping with the wider trend in Pharma, the Exhibitor Innovation Awards will no longer include one dedicated sustainability category.

Distribution 72

Distribution Pharma Pharmaceutical Patients 72

Pharmaceutical Commerce

MARCH 21, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Tiara Green, Interim CEO, Accessia Health offers insight on challenges faced by patient assistance organizations and how to face them.

Patients 52

Patients Pharma 52

Clarivate

APRIL 18, 2024

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. More recent developments provide a look into Amazon’s interest in treating patients with chronic conditions, including a pharmacy consultation pilot for high-risk seniors with complex medical needs.

Retail 52

Retail Healthcare Healthcare Physicians 52

Pharmacy Times

JANUARY 2, 2024

True patient centricity treats the whole patient and places an emphasis on broader patient engagement and satisfaction.

Patients 55

Patients Pharma 55

Pharmaceutical Commerce

MARCH 20, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Monique French, MPH, Senior Director, Patient Advocacy, Health Policy & Communications, Rx4Good provides insight on engaging multiple healthcare groups.

Patients 52

Patients Pharma Healthcare Healthcare 52

PM360

FEBRUARY 22, 2024

The goal was to expand the Patient Savings and Coverage services to include Education and Health Insurance content as well as reset the site’s foundation to accommodate a growing portfolio of brands and services.

Pharma 52

Pharma Insurance Management Education 52

PM360

FEBRUARY 22, 2024

Bronze Winner – BrightInsight and CSL Behring The Hizentra App The Hizentra® app was developed to support patients transitioning from in-clinic treatment to at-home self-infusions of Hizentra and to stay compliant. We conducted interviews with patients and physicians to understand the challenges in moving to selfadministered infusions.

Engineering 52

Engineering Pharma Doctors Management 52

Clarivate

JANUARY 8, 2024

The annual Clarivate Drugs to Watch report for 2024 features 13 new therapeutics with standout commercial and/or clinical potential. These new treatments hold tremendous promise to advance patient care and fuel the next generation of medical breakthroughs. and predict $1.77 billion in revenues for the G7 markets by 2029.

Marketing 59

Marketing Patients Healthcare Healthcare 59

PM360

FEBRUARY 23, 2024

The team worked directly with the MG patient community to build a clean story, then the team embraced an educational yet youthful film style.

Education 52

Education Pharma Leads Marketing 52

PM360

FEBRUARY 23, 2024

Patients & Purpose and Novavax Novavax We Do Vaccines TikTok Campaign Our goal was to use TikTok for “edutainment”— letting people know about Novavax and its protein-based COVID-19 vaccines.

Media 52

Media Pharma Management Patients 52

PM360

FEBRUARY 23, 2024

The customer also stressed the importance of understanding the unique characteristics of the condition in patients with skin of color.

Key account management 52

Key account management Pharma Management Education 52

Pharmaceutical Commerce

MARCH 19, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling.

Patients 52

Patients Pharma 52

Fierce Pharma

FEBRUARY 7, 2024

were receiving the amyloid-busting antibody as of Jan. 26, Eisai explained in a third-quarter earnings presentation.

FDA 222

FDA Patients 222

PharmExec

FEBRUARY 13, 2024

Embracing business imperatives such as operational efficiency and a focus on a patient-centric approach can help pharma leaders provide a stable foundation amid lingering uncertainty.

Pharma 52

Pharma Patients 52

PM360

FEBRUARY 8, 2024

The campaign helped showcase the ability of VNS patients to experience improved quality of life by illustrating everyday activities. VNS Therapy is a Life-changer VNS (vagus nerve stimulation) Therapy is designed for people living with seizures despite trying multiple medications.

Pharma 52

Pharma Sales Management Healthcare 52

PM360

FEBRUARY 8, 2024

ConcentricLife and Jazz Pharmaceuticals The Elephant in the Room Research shows HCPs and patients are aware that some narcolepsy medications contain an excessive amount of sodium, but they are not thinking about the associated risk.

Pharma 52

Pharma Management Marketing Medical 52

PM360

FEBRUARY 8, 2024

It provides an easier experience for HCPs to navigate between critical data and resources when making important treatment decisions for patients with HR+/HER2- mBC.seizure control. This streamlined website experience features the LIFE campaign and brings this idea front and center.

Pharma 52

Pharma Management Leads Medical 52

Contrarian Sales Techniques

FEBRUARY 13, 2024

So, you've got your sights set on the pharmaceutical sales world for 2024, huh? Why choose pharma sales job? Breaking into pharma sales is like trying to get backstage at a sold-out concert (think Cold Play for Malaysians). Understanding the Role First things first, what does a day in the life of a pharma sales rep look like?

Pharmaceutical Sales 52

Pharmaceutical Sales Sales Pharma sales reps Pharmaceutical 52

pharmaphorum

AUGUST 31, 2022

Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners. The post Novartis extends Kaiku digital patient monitoring partnership appeared first on.

Patients 114

Patients Electronics Management Pharma 114

European Pharmaceutical Review

MAY 1, 2024

By providing pharma companies with a real-life replicable model of a cloud-first manufacturing facility, we will drive forward the digital capability of pharma manufacturers” A new digital collaboration is set to take advantage of a manufacturing facility model featuring innovative technologies, accelerating how fast new medicines are made.

Medicine 92

Medicine Manufacturing Pharma Government 92

PharmExec

APRIL 25, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma Patients 52

PM360

FEBRUARY 8, 2024

Utilizing watercolor artwork representing real patients, the campaign and website have been effective at driving connections and advocacy.

Pharma 52

Pharma Healthcare Healthcare Management 52

PM360

FEBRUARY 8, 2024

The cage symbolizes the symptoms of iMCD that may leave a patient feeling trapped and how SYLVANT can help open the door to a patient’s life through treatment. iMCD can present with a wide range of symptoms.

Pharma 52

Pharma Medical sales Management Medical 52

pharmaphorum

JANUARY 9, 2023

is to acquire the 2015-established Amryt Pharma Plc. Chief executive officer of Chiesi Group , Marco Vecchia, said: “This addition of the Amryt portfolio, as well as their expertise, will help us on our journey to bring medicines to patients, no matter how rare their condition may be.”. in an all-cash transaction at $14.50

Pharma 94

Pharma Biopharma Management Medicine 94

European Pharmaceutical Review

APRIL 15, 2024

Positive data from MaaT Pharma’s Microbiome Ecosystem Therapy TM (MET) MaaT013 as a treatment for acute graft-versus-host disease (aGvHD), is set to be presented at the 2024 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting. This data summary is based on an abstract from the Annual Meeting.

Pharma 89

Pharma Patients Management Leads 89

World of DTC Marketing

AUGUST 30, 2022

Although growth in digital budgets is slowing, we estimate the category will see nearly $20 billion in spending in 2024. So why is pharma wasting so much money? Display is an incredibly low-effort way to spend your marketing budget, whether trying to reach physicians or patients.

Physicians 270

Physicians Marketing Pharma Insurance 270

European Pharmaceutical Review

MAY 10, 2024

These advanced medical treatments provide hope for patients suffering from conditions that have historically been poorly understood and widely considered incurable, including genetic diseases and cancers. Preventative measures should be implemented to reduce any potential delays which could prove disastrous for patients.

Medicine 81

Medicine Transportation Patients Government 81

Pharmaceutical Technology

JANUARY 29, 2024

The upcoming OCT West Coast 2024 conference will feature experts talking about emerging techologies, clinical trial operations for pharma and medical devices, and patient participation in studies.

Pharma 52

Pharma Medical Patients 52

PM360

APRIL 22, 2024

This is especially relevant in biopharmaceutical patient engagement, where regulatory infractions can have existential consequences. The Unique Challenges of Patient/Pharma Interaction Patient engagement has become a critical component of medical marketing.

Patients 52

Patients Biopharma Ethics Marketing 52

European Pharmaceutical Review

JANUARY 2, 2024

AstraZeneca highlighted that beneficially, the Gracell FasTCAR platform significantly shortens manufacturing time, enhances T cell fitness and could improve the effectiveness of autologous CAR-T treatment in patients. The transaction is expected to close in the first quarter of 2024, subject to certain closing conditions.

Manufacturing 81

Manufacturing Marketing Engineering Pharma 81

European Pharmaceutical Review

NOVEMBER 21, 2023

Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. The pharma company stated that if successful, it has the potential to reduce greenhouse gas emissions from use of the inhaler by approximately 90 percent.

Manufacturing 109

Manufacturing Patients Pharma Leads 109

PM360

MARCH 22, 2024

We’re featuring AI in this month’s issue as the topic can’t be ignored—generative AI is creating huge waves in the Pharma industry and it’s all we’re talking about. There are ethical considerations around AI in Pharma, from protecting intellectual property, to providing accurate information, to programming bias, to name a few.

Ethics 52

Ethics Pharma Specialization Healthcare 52

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. To learn more about key domestic and multinational company drugs launching into the Mainland China marketplace, please download our Drugs to Watch 2024 report.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

European Pharmaceutical Review

FEBRUARY 14, 2024

percent for patients on seladelpar versus 20.0 percent for patients on seladelpar versus 0.0 ” The transaction is expected to close during the first quarter of 2024, subject to certain customary closing conditions. percent for placebo Normalisation of alkaline phosphatase at 12 months – 25.0

Transportation 81

Transportation Patients Pharma Leads 81

European Pharmaceutical Review

DECEMBER 11, 2023

Results from MaaT Pharma’s Early Access Program (EAP) for its microbiome-based therapy MaaT013, have demonstrated positive overall response and overall survival rates in European patients with graft-versus-host disease (GvHD). Complete response was observed in 51 percent of these patients.

Patients 115

Patients Pharma Pharmaceutical 115